Hiroyuki Matsuda
Directeur/Membre du Conseil chez Aqumen Biopharmaceuticals KK
Profil
Hiroyuki Matsuda is currently the Director & Vice President at Aqumen Biopharmaceuticals KK.
Previously, he worked as a Principal at Rohto Pharmaceutical Co., Ltd.
and Alcon Laboratories, Inc. He also served as an Associate Professor-Eye Research Institute at Oakland University (Michigan).
Dr. Matsuda completed his undergraduate and doctorate degrees at Kanazawa University.
Postes actifs de Hiroyuki Matsuda
| Sociétés | Poste | Début |
|---|---|---|
Aqumen Biopharmaceuticals KK
 Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Aqumen Biopharmaceuticals KK is a holding company that provides research and development of therapeutic medicines for macular degeneration. It also develops therapeutics for diabetic retinopathy, diabetic nephropathy, adjuvants for ophthalmic surgery, and intraocular drug delivery systems. The firm's products encompass the ILM-Blue and the MembraneBlue-Dual. The company was founded by Kimihiko Fujisawa and Tadahisa Kagimoto on April 11, 2005 and is headquartered in Fukuoka, Japan. | Directeur/Membre du Conseil | 01/01/2006 |
Anciens postes connus de Hiroyuki Matsuda
| Sociétés | Poste | Fin |
|---|---|---|
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Corporate Officer/Principal | - |
| Oakland University (Michigan) | Corporate Officer/Principal | - |
| ROHTO PHARMACEUTICAL CO.,LTD. | Corporate Officer/Principal | - |
Formation de Hiroyuki Matsuda
| Kanazawa University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ROHTO PHARMACEUTICAL CO.,LTD. | Consumer Non-Durables |
| Entreprise privées | 2 |
|---|---|
Aqumen Biopharmaceuticals KK
Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Aqumen Biopharmaceuticals KK is a holding company that provides research and development of therapeutic medicines for macular degeneration. It also develops therapeutics for diabetic retinopathy, diabetic nephropathy, adjuvants for ophthalmic surgery, and intraocular drug delivery systems. The firm's products encompass the ILM-Blue and the MembraneBlue-Dual. The company was founded by Kimihiko Fujisawa and Tadahisa Kagimoto on April 11, 2005 and is headquartered in Fukuoka, Japan. | Health Technology |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
